Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

German coalition launches breast cancer screening:

This article was originally published in Clinica

Executive Summary

The German Social Democratic and Green parties are to put forward a joint proposal to assure quality maintenance within a future national mammography screening programme. Breast cancer experts are concerned that, while incidence of the disease fell in both the US and the UK during the 1990s, Germany registered a slight rise. At present, statutory health insurance funds will only reimburse mammography screening if there is a strong indication that the patient has contracted breast cancer. The proposal, which is due to be processed next week, will seek to address concerns that deaths from breast cancer of women between the ages of 50-70 could be reduced by 20-30% were a routine population screening programme to be introduced.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT071807

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel